APP and Alzheimer disease: Not only neurodevelopmental, but also neurodegenerative disorders have been associated with alterations in GABABRs. For example, GABAB(1a,2) receptors have been shown to interact with APP through the sushi domains [45] and a decrease of the GABABR number has been shown in Alzheimer’s disease (AD) patients [148] and in AD animal models [149].